Literature DB >> 6350912

Mesangial IgM nephropathy.

A Tejani, A D Nicastri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6350912     DOI： 10.1159/000183035

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  7 in total

1.  Is cyclophosphamide effective in patients with IgM-positive minimal change disease?

Authors:  Pavel Geier; Amani Roushdi; Sylva Skálová; Jennifer Vethamuthu; Gabrielle Weiler; Janusz Feber
Journal:  Pediatr Nephrol       Date:  2012-06-24       Impact factor: 3.714

2.  Precipitated immune complexes of IgM as well as of IgG can bind to rabbit polymorphonuclear leucocytes but only the immune complexes of IgG are readily phagocytosed.

Authors:  R P Furriel; Y M Lucisano; B Mantovani
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

3.  IgM nephropathy in India: a single centre experience.

Authors:  Aruna V Vanikar; Kamal V Kanodia; Rashmi D Patel; Kamlesh S Suthar; Himanshu V Patel; Manoj R Gumber; Hargovind L Trivedi
Journal:  Indian J Pediatr       Date:  2012-08       Impact factor: 1.967

4.  Minimal change disease with IgM+ immunofluorescence: a subtype of nephrotic syndrome.

Authors:  Sarah J Swartz; Karen W Eldin; M John Hicks; Daniel I Feig
Journal:  Pediatr Nephrol       Date:  2009-02-14       Impact factor: 3.714

Review 5.  IgM nephropathy; can we still ignore it.

Authors:  Aruna Vanikar
Journal:  J Nephropathol       Date:  2013-04-01

Review 6.  Focal segmental glomerulosclerosis.

Authors:  I Ichikawa; A Fogo
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

Review 7.  IgM nephropathy: is it closer to minimal change disease or to focal segmental glomerulosclerosis?

Authors:  R Brugnano; R Del Sordo; C Covarelli; E Gnappi; S Pasquali
Journal:  J Nephrol       Date:  2016-02-03       Impact factor: 3.902
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.